Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy by Charlie Henri Viiala, John Kevin Olynyk

“…Charlie Henri Viiala, John Kevin OlynykSchool of Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Perth, Western Australia, AustraliaObjective: To determine factors influencing the low return rate observed in a program of flexible sigmoidoscopy for average risk screening for colorectal carcinoma.Methods: Flexible sigmoidoscopy-based screening of average risk 55–64 yr olds has been ongoing since 1995. …”
Get full text

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant by Ashley McEwan, Omali Pitiyarachchi, Nicholas Viiala

Get full text

PB1871: HIGH RATES OF INFECTION AND RELATED MORALITY FROM VENETOCLAX THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE RETROSPECTIVE STUDY by Durga Chandran, Nicholas Viiala, Anne-Marie Watson, Lindsay Dunlop, Penelope Motum, Nagendraprasad Sungala, Heather Range, Bartlomiej Getta

Get full text

Bronchial artery pseudoaneurysm presenting with hoarseness: Diagnosis and endovascular management by Eric Yu Wei Lo, MBBS, BMedSci, MSc, Nicholas Viiala, MBBS, FRCPA, FRACP, Jules Catt, MBBS (Hons), BSc, MPH, FRANZCR, EBIR, Bruce French, MBBS, FRACS

Get full text

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study by P. Joy Ho, Devendra Hiwase, Raj Ramakrishna, Nicholas Viiala, Ann Solterbeck, Robert Traficante, Evren Zor, Othon L. Gervasio, Laura M. High, David M. Ross, Donald K. Bowden

Get full text

P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12 DIRECT STUDY BASED ON TROUGH LEVELS MINIMISE TOXICITY AND PRESERVE EFFICACY by D. Yeung, A. Grigg, N. Shanmuganathan, A. Soltenbeck, D. White, S. Branford, N. Viiala, P. Rowlings, A. Mills, J. Shortt, C. Tiley, D. Ross, D. Kipp, R. Harrup, I. Cunningham, J. Kwan, R. Eek, H. Mutsando, K.-S. Tan, K. Burbury, M. Wright, T. Hughes, On Behalf of the ALLG

Get full text

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REG... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoff Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes

Get full text

Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes

Get full text